The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy
The current standard regimens for the treatment of acute myeloid leukemia (AML) are curative in less than half of patients; therefore, there is a great need for innovative new approaches to this problem. One approach is to target new treatments to the pathways that are instrumental to cell growth an...
Main Authors: | Elzbieta Gocek, George P. Studzinski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/4/4/504 |
Similar Items
-
Differentiation Therapy of Acute Myeloid Leukemia
by: Elzbieta Gocek, et al.
Published: (2011-05-01) -
Control of Late Cornified Envelope Genes Relevant to Psoriasis Risk: Upregulation by 1,25‐Dihydroxyvitamin D3 and Plant‐derived Delphinidin
by: Hoss, Elika
Published: (2014) -
In Pursuit of Vitamin D in Plants
by: Lucinda J. Black, et al.
Published: (2017-02-01) -
Vitamin D and activated vitamin D in tuberculosis in equatorial Malaysia: a prospective clinical study
by: Anna P. Ralph, et al.
Published: (2017-04-01) -
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
by: Solène Fernandez, et al.
Published: (2019-07-01)